Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-HOBA in POTS
NCT07189936Phase 2Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxybenzylamine in post-COVID-19 condition (PCC), postural orthostatic tachycardia syndrome (POTS), sponsored by Vanderbilt University Medical Center. Started Dec 2025; status: recruiting.
02
Drugs
2-hydroxybenzylamine
03
Conditions
post-COVID-19 condition (PCC)postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT07189936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189936.